Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy (Q46788868)
Jump to navigation
Jump to search
scientific article published on 26 January 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy |
scientific article published on 26 January 2008 |
Statements
1 reference
Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy (English)
1 reference
1 reference
Noriko Usui
1 reference
Masamitsu Yanada
1 reference
Jin Takeuchi
1 reference
Isamu Sugiura
1 reference
Hideki Akiyama
1 reference
Fumiharu Yagasaki
1 reference
Kazuhiro Nishii
1 reference
Yasunori Ueda
1 reference
Makoto Takeuchi
1 reference
Shuichi Miyawaki
1 reference
Atsuo Maruta
1 reference
Hiroto Narimatsu
1 reference
Yasushi Miyazaki
1 reference
Shigeki Ohtake
1 reference
Itsuro Jinnai
1 reference
Tomoki Naoe
1 reference
Ryuzo Ohno
1 reference
Japan Adult Leukemia Study Group
1 reference
26 January 2008
1 reference
1 reference
93
1 reference
2
1 reference
287-290
1 reference